RonaldWittelesMD
Cardiology • Stanford, CAAdult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation
Assistant Professor, Medicine - Cardiovascular Medicine, Stanford University Medical Center
Dr. Witteles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2004 - 2007- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2000 - 2003
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2001 - 2025
OR State Medical License 2020 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Most Compassionate Doctor American Registry
- Fellow (FACC) American College of Cardiology
Clinical Trials
- BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS) Start of enrollment: 2004 Mar 01
- Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure Start of enrollment: 2008 Apr 01
- Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation Start of enrollment: 2021 Apr 01
Publications & Presentations
PubMed
- 39 citationsIncrease in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth FactorSarah Waliany, Kristin L. Sainani, Lesley S. Park, Chiyuan Amy Zhang, Sandy Srinivas
JACC. Cardiooncology. 2019-09-01 - 62 citationsMyocarditis Surveillance with High-Sensitivity Troponin I During Cancer Treatment with Immune Checkpoint Inhibitors.Sarah Waliany, Joel W. Neal, Sunil Reddy, Heather A. Wakelee, Sumit A. Shah
JACC. Cardiooncology. 2021-03-01 - 510 citationsManagement of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendationsGiuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley, Sarju Ganatra, Ana Barac
Annals of Oncology. 2020-02-01
Abstracts/Posters
- Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep ResponsesRonald Witteles, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL AmyloidosisRonald Witteles, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Authored Content
- Summary of Clinical Trials for the Prevention and Treatment of Cardiomyopathy Related to Anthracyclines and HER2-Targeted AgentsJuly 2020
- Summary of Clinical Trials for the Prevention and Treatment of Cardiomyopathy Related to Anthracyclines and HER2-Targeted AgentsJuly 2020
Press Mentions
Atorvastatin Cut Anthracycline Cardiac Dysfunction in LymphomaMarch 4th, 2023- Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC GuidelinesDecember 12th, 2022
- COVID-19 Vaccine Rollout Plagued by Protests, Failed Technology and Front-Line Workers Missing OutDecember 22nd, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
